[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,235 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-06-10 | Class I | JCB Flavors, LLCH-0890-2026 | Products may be potentially contaminated with Salmonella. | Environmental Monitoring |
| 2026-06-10 | Class II | Straus Family CreameryH-0897-2026 | Potential contamination with foreign objects (metal pieces). | Environmental Monitoring |
| 2026-06-10 | Class I | The Coffee Connexion Co., IncH-0908-2026 | Product contains dry milk powder ingredient recalled by the supplier due to potential Salmonella contamination | Environmental Monitoring |
| 2026-06-10 | Class I | SKS Copackfood-20260610-SKS Copack | Products may potentially be contaminated with Salmonella. | Environmental Monitoring |
| 2026-06-10 | Class I | Nassar Investment Company LLCH-0860-2026 | Salmonella. The firm was notified by the North Carolina Department of Agriculture that the product test positive for Salmonella. | Environmental Monitoring |
| 2026-06-10 | Class I | Terra Medi LLCH-0899-2026 | Un-eviscerated fish may be contaminated with clostridium botulinum | Environmental Monitoring |
| 2026-06-10 | Class I | JCB Flavors, LLCH-0886-2026 | Products may be potentially contaminated with Salmonella. | Environmental Monitoring |
| 2026-06-03 | Class I | Medline Industries, LPZ-2231-2026 | Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. | Environmental Monitoring |
| 2026-06-03 | Class I | Medline Industries, LPZ-2237-2026 | Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. | Environmental Monitoring |
| 2026-06-03 | Class I | Medline Industries, LPZ-2235-2026 | Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. | Environmental Monitoring |
| 2026-06-03 | Class I | Medline Industries, LPZ-2233-2026 | Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. | Environmental Monitoring |
| 2026-06-03 | Class II | Medline Industries, LPZ-2260-2026 | Specific Medline Kits contain Cardinal Health Monoject 1mL Luer Lock Syringes, Tuberculin Print, Sterile. Cardinal Health has recalled these syringes because the outer carton and blister pack are labeled as a 1 mL Luer Lock Tuberculin Syringe (Product Code 1180100777), but the syringes inside are U-100 insulin syringes. | Environmental Monitoring |
| 2026-06-03 | Class I | Medline Industries, LPZ-2234-2026 | Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. | Environmental Monitoring |
| 2026-06-03 | Class I | Medline Industries, LPZ-2236-2026 | Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. | Environmental Monitoring |
| 2026-06-03 | Class I | Medline Industries, LPZ-2232-2026 | Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. | Environmental Monitoring |
| 2026-06-03 | Class II | Fly By Jing Inc.H-0854-2026 | Possible cross-contamination resulting in undeclared allergen ingredient (Peanut) | Environmental Monitoring |
| 2026-06-03 | Class I | Legacy Bakehouse LLCH-0851-2026 | Products were made with recalled California Dairies milk powder due to Salmonella. | Environmental Monitoring |
| 2026-06-03 | Class I | Honeyville, IncH-0849-2026 | Firm received and used potentially contaminated (Salmonella) ingredient to manufacture various products. | Environmental Monitoring |
| 2026-06-03 | Class I | Legacy Bakehouse LLCH-0852-2026 | Products were made with recalled California Dairies milk powder due to Salmonella. | Environmental Monitoring |
| 2026-06-03 | Class I | Legacy Bakehouse LLCH-0850-2026 | Products were made with recalled California Dairies milk powder due to Salmonella. | Environmental Monitoring |
| 2026-05-27 | Class III | Amerisource Health Services LLCD-0536-2026 | Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0803-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | Wellnov Supplements LLCH-0800-2026 | Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns. | Environmental Monitoring |
| 2026-05-27 | Class II | UCB Biosciences Inc.D-0546-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
| 2026-05-27 | Class II | Llorens Pharmaceuticals International Division, Inc.H-0809-2026 | Foreign object: black particulate matter | Environmental Monitoring |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.